Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]

Phase II trial of nivolumab combined with ibrutinib for patients with Richter...

Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA

Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )

Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia

Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona...

Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia ( Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )

Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed...

Dr Habte Yimer - Texas Oncology, Tyler, USA

Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma ( Dr Habte Yimer - Texas Oncology, Tyler, USA )

Blinatumomab as second salvage therapy in adults with relapsed/refractory...

Prof Alessandro Rambaldi - University of Milan, Milan, Italy

$Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-NHL ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )$

Efficacy and safety of KRd or KCd induction in multiple myeloma

Dr Francesca Gay - University of Torino, Torino, Italy

Efficacy and safety of KRd or KCd induction in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )

Maintenance therapy with the oral PI ixazomib significantly prolongs PFS...

Dr Francesca Gay - University of Torino, Torino, Italy

Maintenance therapy with the oral PI ixazomib significantly prolongs PFS following ASCT in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )

Results from the EMN-011 trial, combination therapy for multiple myeloma

Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands

Results from the EMN-011 trial, combination therapy for multiple myeloma ( Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative...

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France

Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative disorder in the central nervous system ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )

Clinical impact of an accurate genetic characterisation of older AML patients

Prof Alessandro Rambaldi - University of Milan, Milan, Italy

Clinical impact of an accurate genetic characterisation of older AML patients ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )

Two clinical trials using combination therapy in adult patients with multiple...

Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA

Two clinical trials using combination therapy in adult patients with multiple myeloma ( Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA )

The combined analysis of carfilzomib trials for multiple myeloma

Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain

The combined analysis of carfilzomib trials for multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )

Gilteritinib combined with induction and consolidation chemotherapy in newly...

Dr Keith Pratz - Johns Hopkins University, Baltimore, USA

Gilteritinib combined with induction and consolidation chemotherapy in newly diagnosed AML patients ( Dr Keith Pratz - Johns Hopkins University, Baltimore, USA )

More from ecancer